Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Nosocomial bloodstream infections are important causes of morbidity and mortality. In this study, concurrent surveillance for nosocomial bloodstream infections at 49 hospitals over a 3-year period detected >10,000 infections. Gram-positive organisms accounted for 64% of cases, gram-negative organisms accounted for 27%, and 8% were caused by fungi. The most common organisms were coagulase-negative staphylococci (32%), Staphylococcus aureus (16%), and enterococci (11%). Enterobacter, Serratia, coagulase-negative staphylococci, and Candida were more likely to cause infections in patients in critical care units. In patients with neutropenia, viridans streptococci were significantly more common. Coagulase-negative staphylococci were the most common pathogens on all clinical services except obstetrics, where Escherichia coli was most common. Methicillin resistance was detected in 29% of S. aureus isolates and 80% of coagulase-negative staphylococci. Vancomycin resistance in enterococci was species-dependent--3% of Enterococcus faecalis strains and 50% of Enterococcus faecium isolates displayed resistance. These data may allow clinicians to better target empirical therapy for hospital-acquired cases of bacteremia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Candida species are the fourth most common cause of hospital-acquired bloodstream infections (BSI) in the United States (5, 9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
In the citing paper
“These species proportions are very similar to those previously reported from the northeastern United States (9).”
In the citing paper
“The National Epidemiology of Mycoses Survey study demonstrated geographic variations in species distributions throughout the United States, with C. albicans ranging from 46% in the northeast to 70% in the southwest and C. glabrata ranging from 15% in the southwest to 26% in the northeast (9).”
In the citing paper
“Other population-based and sentinel surveillance studies of nosocomial candidiasis, although not longitudinal in design, also showed that the proportion of fungemia due to C. albicans remained almost constant throughout the 1990s at about 50% and that the proportion due to Candida species other than C. albicans ranged from 42 to 48% (8, 9, 16, 26; reviewed in reference 23).”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984 · cited 3×
“Nonetheless, prospective surveillance projects such as ours will allow rapid detection of such infections, which initially appeared in Japan [17, 18] and have been reported in the United States [19].”
BackgroundHiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
Pittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 1×
“Several subprojects have evaluated samples of organisms from this study and have included validation measures, such as reidentification of species and retesting of antimicrobial susceptibilities in the Special Microbiology Laboratory at the University of Iowa College of Medicine [6–14].”
BackgroundSelf-citationPfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00240-x · Cited by 331
Self-citationCeftazidime Resistance Among Selected Nosocomial Gram-Negative Bacilli In The United States
Burwen, D. R., Banerjee, S. N., Gaynes, R. P., & System, T. N. N. I. S. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.6.1622 · Cited by 214
The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study
Ena, J. (1993) · JAMA · doi:10.1001/jama.269.5.598 · Cited by 203
Jones, R. N., Marshall, S. A., Pfaller, M. A., Wilke, W. W., Hollis, R. J., Erwin, M. E., Edmond, M. B., & Wenzel, R. P. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00115-6 · Cited by 153
Self-citationMarshall, S. A., Wilke, W. W., Pfaller, M. A., & Jones, R. N. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00212-5 · Cited by 146
Self-citationAntimicrobial Resistance: Issues and Options
(1998) · National Academies Press eBooks · doi:10.17226/6121 · Cited by 129
Cited by
Items 201–300 of 1,001
Horvath, L. L., George, B. J., Murray, C. K., Harrison, L. S., & Hospenthal, D. R. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.115-118.2004 · Cited by 136
Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy
Moise, P. A., Hershberger, E., Amodio-Groton, M. I., & Lamp, K. C. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m085 · Cited by 136
Li, Z., Willke, R. J., Pinto, L. A., Rittenhouse, B., Rybak, M. J., Pleil, A. M., Crouch, C. W., Hafkin, B., & Glick, H. A. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.3.263.34198 · Cited by 135
Alicyclic β-amino acids in Medicinal Chemistry
Kühl, A., Hahn, M. G., Dumić, M., & Mittendorf, J. (2005) · Amino Acids · doi:10.1007/s00726-005-0212-y · Cited by 133
Schüetz, P., Müeller, B., & Trampuž, A. (2007) · Infection · doi:10.1007/s15010-007-7065-0 · Cited by 133
Pem�n, J., Cant�n, E., Gobernado, M., & and the Spanish ECMM Working Group on Candidaemia (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1267-5 · Cited by 133
Recent experience with fungaemia: change in species distribution and azole resistance
Chakrabarti, A., Chatterjee, S. S., Rao, K. L. N., Zameer, M. M., Shivaprakash, M. R., Singhi, S., Singh, R., & Varma, S. C. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902777105 · Cited by 132
Microbiologic evaluation of commercial probiotics
Weese, J. S. (2002) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2002.220.794 · Cited by 131
Mechanisms of Fungal Resistance: An Overview
Balkis, M. M., Leidich, S. D., Mukherjee, P. K., & Ghannoum, M. A. (2002) · Drugs · doi:10.2165/00003495-200262070-00004 · Cited by 130
Tumor Necrosis Factor Inhibition and Invasive Fungal Infections
Filler, S. G., Yeaman, M. R., & Sheppard, D. C. (2005) · Clinical Infectious Diseases · doi:10.1086/430000 · Cited by 121
Alexander, B. D., Byrne, T. C., Smith, K. L., Hanson, K. E., Anstrom, K. J., Perfect, J. R., & Reller, L. B. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01840-06 · Cited by 129
Diekema, D. J., Pfaller, M. A., & Jones, R. N. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00204-2 · Cited by 129
Self-citationPolk, R. E., Johnson, C. K., McClish, D. K., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/422647 · Cited by 127
Self-citationAntifungal Activity of Coumarin Against Candida albicans Is Related to Apoptosis
Jia, C., Zhang, J., Yu, L., Wang, C., Yang, Y., Rong, X., Xu, K., & Chu, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00445 · Cited by 126
Rodríguez‐Créixems, M., Alcalá, L., Muñóz, P., Cercenado, E., Vicente, T., & Bouza, E. (2008) · Medicine · doi:10.1097/md.0b013e318182119b · Cited by 126
May, L. S., Klein, E. Y., Rothman, R. E., & Laxminarayan, R. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01908-13 · Cited by 125
Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage
Ohlsen, K., Ternes, T., Werner, G., Wallner, U., Löffler, D., Ziebuhr, W., Witte, W., & Hacker, J. (2003) · Environmental Microbiology · doi:10.1046/j.1462-2920.2003.00459.x · Cited by 124
Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents
HILMY, K. M. H., Khalifa, M. M., Hawata, M. A. A., Keshk, R. M., & El-Torgman, A. A. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.043 · Cited by 123
Jayatilake, J. A. M. S., Samaranayake, Y. H., Cheung, L. K., & Samaranayake, L. P. (2006) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2006.00435.x · Cited by 123
Caspofungin Activity against Clinical Isolates of Fluconazole-Resistant Candida
Pfaller, M. A., Messer, S. A., Boyken, L. B., Rice, C., Tendolkar, S., Hollis, R. J., & Diekema, D. J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.12.5729-5731.2003 · Cited by 123
Self-citationFisiopatogenia, epidemiologia e diagnóstico laboratorial da candidemia
Giolo, M. P., & Svidzinski, T. I. E. (2010) · Jornal Brasileiro de Patologia e Medicina Laboratorial · doi:10.1590/s1676-24442010000300009 · Cited by 122
Candidemia in Finland, 1995–1999
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., & Ruutu, P. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030069 · Cited by 121
Direct Isolation of Candida spp. from Blood Cultures on the Chromogenic Medium CHROMagar Candida
Horvath, L. L., Hospenthal, D. R., Murray, C. K., & Dooley, D. P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2629-2632.2003 · Cited by 81
Nosocomial Bloodstream Infections in Finnish Hospitals during 1999–2000
Lyytikäinen, O., Lumio, J., Sarkkinen, H., Kolho, E., KOSTIALA, A. A. I., & Ruutu, P. (2002) · Clinical Infectious Diseases · doi:10.1086/340981 · Cited by 121
Bhattacharjee, P. (2016) · Current Medical Mycology · doi:10.18869/acadpub.cmm.2.2.5 · Cited by 120
Copper(II) complexes of coumarin-derived Schiff bases and their anti-Candida activity
Creaven, B. S., Devereux, M. M., Karcz, D., Kellett, A., McCann, M., Noble, A., & Walsh, M. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.05.017 · Cited by 119
Bedini, A., Venturelli, C., Mussini, C., Guaraldi, G., Codeluppi, M., Borghi, V., Rumpianesi, F., Barchiesi, F., & Esposito, R. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01310.x · Cited by 118
Choi, J., Kang, O., Lee, Y., Oh, Y.-C., Chae, H., Jang, H.-J., Shin, D.-W., & Kwon, D. (2009) · Molecules · doi:10.3390/molecules14051773 · Cited by 118
Takakura, S. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh053 · Cited by 117
Rationale for Combination Antifungal Therapy
Lewis, R. E., & Kontoyiannis, D. P. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.149s.34505 · Cited by 117
Nosocomial bloodstream infections in ICU and non-ICU patients
Šuljagić, V., Cobeljić, M., Janković, S., Mirović, V., Markovic‐Denic, L., Romić, P., & Mikić, D. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.03.010 · Cited by 117
Tortorano, A. M., Biraghi, E., Astolfi, A., Ossi, C., Tejada, M., Farina, C., Perin, S., Bonaccorso, C., Cavanna, C., Raballo, A., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1261 · Cited by 116
Maschmeyer, G., & Braveny, I. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000410 · Cited by 115
Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry
Marinach, C., Fekkar, A., Atanasova, R., Gomes, J., Djamdjian, L., Brossas, J., Meyer, I., Buffet, P. A., Snounou, G., Datry, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008862 · Cited by 114
Development of a real-time Staphylococcus aureus and MRSA (SAM-) PCR for routine blood culture
Thomas, L. C., Gidding, H. F., Ginn, A. N., Olma, T., & Iredell, J. R. (2006) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2006.09.003 · Cited by 113
Wheeler, D. S., Giaccone, M. J., Hutchinson, N., Haygood, M., Bondurant, P., Demmel, K., Kotagal, U. R., Connelly, B. L., Corcoran, M. S., Line, K., et al. (2011) · PEDIATRICS · doi:10.1542/peds.2010-2601 · Cited by 112
Infection control: the case for horizontal rather than vertical interventional programs
Wenzel, R. P., & Edmond, M. B. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.05.002 · Cited by 112
Self-citationSpanu, T., Sanguinetti, M., Ciccaglione, D., D’Inzeo, T., Romano, L., Leone, F., & Fadda, G. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4259-4263.2003 · Cited by 112
Lautenbach, E., LaRosa, L. A., Marr, A. M., Nachamkin, I., Bilker, W. B., & Fishman, N. O. (2003) · Clinical Infectious Diseases · doi:10.1086/346153 · Cited by 112
Mechanisms of Resistance to Imipenem and Ampicillin in Enterococcus faecalis
Ono, S., Muratani, T., & Matsumoto, T. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2954-2958.2005 · Cited by 111
Tan, T. Y., Corden, S. A., Barnes, R. A., & Cookson, B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4529-4531.2001 · Cited by 111
Estimating the Cost of Nosocomial Candidemia in the United States
Miller, L. G., Hajjeh, R. A., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/319613 · Cited by 109
The changing epidemiology of invasive fungal infections: new threats
Maschmeyer, G. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.03.006 · Cited by 109
Candida albicansactively modulates intracellular membrane trafficking in mouse macrophage phagosomes
Fernández‐Arenas, E., Bleck, C. K. E., Nombela, C., Gil, C., Griffiths, G., & Diez‐Orejas, R. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01274.x · Cited by 109
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
Poikonen, E., Lyytikäinen, O., Anttila, V.-J., Koivula, I., Lumio, J., Kotilainen, P., Syrjälä, H., & Ruutu, P. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-312 · Cited by 109
Zaoutis, T. E., Jafri, H. S., Huang, L.-M., Locatelli, F., Barzilai, A., Ebell, W., Steinbach, W. J., Bradley, J., Lieberman, J. M., Hsiao, C.-C., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-1158 · Cited by 108
Grim, S. A., Rapp, R. P., Martin, C. A., & Evans, M. E. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.2.253.56956 · Cited by 108
Bromuro, C., Torosantucci, A., Chiani, P., Conti, S., Polonelli, L., & Cassone, A. (2002) · Infection and Immunity · doi:10.1128/iai.70.10.5462-5470.2002 · Cited by 92
Theiss, S., Ishdorj, G., Brenot, A., Kretschmar, M., Lan, C.-Y., Nichterlein, T., Hacker, J., Nigam, S., Agabian, N., & Köhler, G. A. (2006) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2006.03.003 · Cited by 107
Smith, P. B., Benjamin, D. K., Alexander, B. D., Johnson, M. D., Finkelman, M. A., & Steinbach, W. J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00025-07 · Cited by 101
Okoli, I., Coleman, J. J., Tempakakis, E., An, W. F., Holson, E., Wagner, F., Conery, A. L., Larkins-Ford, J., Wu, G., Stern, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007025 · Cited by 106
Assessment of the Safety and Pharmacokinetics of Anidulafungin When Administered With Cyclosporine
Dowell, J. A., Stogniew, M., Krause, D., Henkel, T., & Weston, I. E. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004270146 · Cited by 106
Epidemiology and antifungal resistance in invasive candidiasis
Rodloff, A., Koch, D., & Schaumann, R. (2011) · European Journal of Medical Research · doi:10.1186/2047-783x-16-4-187 · Cited by 88
Expression analysis of the lipase gene family during experimental infections and in patient samples
STEHR, F., FELK, A., GACSER, A., KRETSCHMAR, M., MAHNS, B., NEUBER, K., HUBE, B., & SCHAFER, W. (2004) · FEMS Yeast Research · doi:10.1016/s1567-1356(03)00205-8 · Cited by 105
Recent Approaches to Antifungal Therapy for Invasive Mycoses
Mathew, B. P., & Nath, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200800353 · Cited by 105
Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis
Bendel, C. M. (2003) · Seminars in Perinatology · doi:10.1016/s0146-0005(03)00059-4 · Cited by 105
Lewis, R. E., Kontoyiannis, D. P., Darouiche, R. O., Raad, I. I., & Prince, R. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3499-3505.2002 · Cited by 96
Candida albicans specializations for iron homeostasis: from commensalism to virulence
Noble, S. M. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.09.006 · Cited by 104
Systemic mycoses in the immunocompromised host: an update in antifungal therapy
Kontoyiannis, D. P., Mantadakis, E., & Samonis, G. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1278 · Cited by 104
Lau, A. F., Sorrell, T. C., Chen, S., Stanley, K. K., Iredell, J. R., & Halliday, C. L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00689-08 · Cited by 104
Control of morphogenesis in the human fungal pathogen Penicillium marneffei
Andrianopoulos, A. (2002) · International Journal of Medical Microbiology · doi:10.1078/1438-4221-00217 · Cited by 104
Khodavandi, A., Alizadeh, F., Aala, F., Sekawi, Z., & Chong, P. P. (2009) · Mycopathologia · doi:10.1007/s11046-009-9251-3 · Cited by 103
Meyer, M.-H., Letscher‐Bru, V., Jaulhac, B., Waller, J., & Candolfi, E. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.2.773-777.2004 · Cited by 103
Nishimoto, A. T., Sharma, C., & Rogers, P. D. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz400 · Cited by 102
Airborne bacteria and antibiotic resistance genes in hospital rooms
Gilbert, Y., Veillette, M., & Duchaine, C. (2010) · Aerobiologia · doi:10.1007/s10453-010-9155-1 · Cited by 102
Lim, S. ‐., & Webb, S. A. R. (2005) · Anaesthesia · doi:10.1111/j.1365-2044.2005.04220.x · Cited by 101
RAAD, I. I., Kassar, R., Ghannam, D., Chaftari, A., Hachem, R. Y., & Jiang, Y. (2009) · Clinical Infectious Diseases · doi:10.1086/605694 · Cited by 101
In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model
Andes, D., Marchillo, K., Lowther, J., Bryskier, A., Stamstad, T., & Conklin, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1187-1192.2003 · Cited by 100
Hoehamer, C. F., Cummings, E. D., Hilliard, G. M., & Rogers, P. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-09 · Cited by 100
Shuford, J. A., Rouse, M. S., Piper, K. E., Steckelberg, J. M., & Patel, R. (2006) · The Journal of Infectious Diseases · doi:10.1086/506452 · Cited by 99
Hoste, E. A. J., Blot, S. I., Lameire, N. H., Vanholder, R. C., De Bacquer, D., & Colardyn, F. A. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000110182.14608.0c · Cited by 99
New investigational antifungal agents for treating invasive fungal infections
Hossain, M. A., & Ghannoum, M. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1797 · Cited by 95
Chakhaiyar, P., Nagalakshmi, Y., Aruna, B., Murthy, K. J. R., Katoch, V. M., & Hasnain, S. E. (2004) · The Journal of Infectious Diseases · doi:10.1086/423938 · Cited by 99
Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo
Mukherjee, P. K., Seshan, K. R., Leidich, S. D., Chandra, J., Cole, G. T., & Ghannoum, M. A. (2001) · Microbiology · doi:10.1099/00221287-147-9-2585 · Cited by 98
Lerma, L. L., Benomar, N., Valenzuela, A. S., Muñoz, M. D. C. C., Gálvez, A., & Abriouel, H. (2014) · Food Microbiology · doi:10.1016/j.fm.2014.06.009 · Cited by 98
Pallasch, T. J. (2003) · Dental Clinics of North America · doi:10.1016/s0011-8532(03)00039-9 · Cited by 98
Activities of Micafungin against 315 Invasive Clinical Isolates of Fluconazole-Resistant Candida spp
Messer, S. A., Diekema, D. J., Boyken, L., Tendolkar, S., Hollis, R. J., & Pfaller, M. A. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.2.324-326.2006 · Cited by 97
Self-citationVale-Silva, L. A., Coste, A. T., Ischer, F., Parker, J. E., Kelly, S. L., Pinto, E., & Sanglard, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05720-11 · Cited by 97
Dimopoulos, G., Karabinis, A., Samonis, G., & Falagas, M. E. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0316-2 · Cited by 97
Frank, C. F., & Hostetter, M. K. (2007) · Translational research · doi:10.1016/j.trsl.2006.11.006 · Cited by 97
McBride, S., Upton, A., & Roberts, S. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0830-5 · Cited by 97
Ferreira, J. A. G., Carr, J. H., Starling, C. E. F., de Resende, M. A., & Donlan, R. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00316-09 · Cited by 84
Sweet, M. A., Cumpston, A., Briggs, F., Craig, M., & Hamadani, M. (2012) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.01.025 · Cited by 96
Pulmonary and Blood Stream Infections in Adult Living Donor and Cadaveric Liver Transplant Patients
Saner, F. H., Damink, S. W. M. O., Pavlaković, G., van den Broek, M. A. J., Rath, P., Sotiropoulos, G. C., Radtke, A., Canbay, A. E., Paul, A., Nadalin, S., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e31816f61a6 · Cited by 95
Epidemiology and Clinical Outcomes of Infective Endocarditis in Hemodialysis Patients
Kamalakannan, D., Pai, R., Johnson, L. B., Gardin, J. M., & Saravolatz, L. D. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.02.033 · Cited by 95
Future directions for anti-biofilm therapeutics targetingCandida
Nett, J. E. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.885838 · Cited by 95
Kassis, C., Rangaraj, G., Jiang, Y., Hachem, R. Y., & RAAD, I. I. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01045-09 · Cited by 95
Mille, C., Bobrowicz, P., Trinel, P.-A., Li, H., Maes, E., Guerardel, Y., Fradin, C., Martínez-Esparza, M., Davidson, R. C., Janbon, G., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708825200 · Cited by 94
Wells, C. L., Moore, E. A., Hoag, J. A., Hirt, H., Dunny, G. M., & Erlandsen, S. L. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7190-7194.2000 · Cited by 93
The role of the cell wall in fungal pathogenesis
Arana, D. M., Prieto, D., Román, E., Nombela, C., Alonso‐Monge, R., & Pla, J. (2009) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2008.00070.x · Cited by 92
Shupp, J. W., Pavlovich, A. R., Jeng, J. C., Pezzullo, J. C., Oetgen, W. J., Jaskille, A. D., Jordan, M. H., & Shoham, S. (2010) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3181e4d5e7 · Cited by 92
Action mechanisms of probiotics on Candida spp. and candidiasis prevention: an update
Ribeiro, F. D. C., Rossoni, R. D., de Barros, P. P., dos Santos, J. D., Fugisaki, L. R. D. O., Leão, M. V. P., & Junqueira, J. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14511 · Cited by 91
Stokes, C., Moran, G. P., Spiering, M. J., Cole, G. T., Coleman, D. C., & Sullivan, D. J. (2007) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2006.11.014 · Cited by 91
Pulimood, S., Ganesan, L. P., Alangaden, G. J., & Chandrasekar, P. H. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00460-1 · Cited by 91
Surgimiento y diseminación de Staphylococcus aureus meticilinorresistente
Velázquez-Meza, M. E. (2005) · Salud Pública de México · doi:10.1590/s0036-36342005000500009 · Cited by 90
Hair, P. I., & Keam, S. J. (2007) · Drugs · doi:10.2165/00003495-200767100-00008 · Cited by 90
Hüebner, J., Quaas, A. M., Krueger, W. A., Goldmann, D. A., & Pier, G. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4631-4636.2000 · Cited by 90
Favre, B., Hugonnet, S., Corrêa, L., Sax, H., Rohner, P., & Pittet, D. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502605 · Cited by 90
Segreti, J. A., Crank, C. W., & Finney, M. S. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.3.347 · Cited by 88
Banerjee, M., Uppuluri, P., Zhao, X. R., Carlisle, P. L., Vipulanandan, G., Villar, C. C., López-Ribot, J. L., & Kadosh, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00163-12 · Cited by 88
Metadata
- Authors
- Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P.
- Affiliations
- Virginia Commonwealth University (US)
- Corresponding author
- Wenzel, Richard P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-08
- Volume
- 29
- Issue
- 2
- Pages
- 239-244
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157766752
- Cited by
- 1,387
- References
- 16
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 13 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 37 · 2018: 31 · 2017: 36 · 2016: 41 · 2015: 33 · 2014: 56 · 2013: 55 · 2012: 55
- FWCI
- 47.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- nosocomial bloodstream infection, hospital-acquired bacteremia, coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus, Gram-positive bacteria, Gram-negative bacteria, fungemia, methicillin resistance, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, Streptococcus viridans, neutropenia, intensive care unit, empirical antibiotic therapy, infection surveillance
- MeSH terms
- Candida, Cross Infection, Gram-Negative Bacteria, Gram-Positive Bacteria, Hospitals, Humans, Neutropenia, Staphylococcus, United States, Fungemia, Bacteremia, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.